Houston Methodist’s Post

View organization page for Houston Methodist, graphic

129,245 followers

Professor of Cardiovascular Surgery Dr. Michael Reardon presented late-breaking one-year outcomes of the ACURATE IDE trial, which looked at ACURATE neo2 vs approved TAVR devices in all-risk patients with severe aortic stenosis at #TCT2024. http://spr.ly/6048S6qpn

Deniz D

Aspiring IT manager at Microsoft

1w

Love this 😍😻🥰🤩😁😇😃🧼

To view or add a comment, sign in

Explore topics